» Guerbet obtains one million euros from the BPI for its AI project in the early detection of pancreatic cancer MyPharma Editions

Guerbet obtains one million euros from the BPI for

Posted on Tuesday, September 27, 2022 Guerbet obtains funding of one million euros from the State via France 2030 following its participation in a call for projects concerning the acceleration strategy in digital health. The presentation of the work of Guerbet’s Artificial Intelligence (AI) research team, which could potentially offer a promising response to a … Read more

» Pancreatic cancer: Oncodesign Precision Medicine and Servier will collaborate to discover new therapeutic targets MyPharma Editions

Pancreatic cancer Oncodesign Precision Medicine and Servier will collaborate

Posted on Friday, September 23, 2022 Servier, an international pharmaceutical group, and Oncodesign Precision Medicine (OPM), a subsidiary of Oncodesign specializing in precision medicine, announce a collaborative research agreement, called “STarT Pancreas”, for the identification and validation of new therapeutic targets aimed at the development of new treatments for pancreatic ductal adenocarcinoma (PDAC). For a … Read more

Oncodesign Precision Medicine (OPM) and Servier announce the signing of a strategic collaboration for the discovery of new therapeutic targets in the treatment of pancreatic cancer – La Bourse et la Vie TV

Oncodesign Precision Medicine OPM and Servier announce the signing of

Identification and validation of new therapeutic targets against pancreatic cancer Construction of a common Artificial Intelligence (AI) analytical platform Generation and pooling of clinical and biological data, AI tools and skills in experimental pharmacology Servier can initiate a partnership with OPM in Drug Discovery based on certain targets discovered thanks to this technological approach SURESNES, … Read more

Pancreatic cancer: artificial intelligence can detect the first signs of the disease

Pancreatic cancer artificial intelligence can detect the first signs of

⇧ [VIDÉO] You might also like this partner content (after ad) Pancreatic cancer remains one of the most difficult to treat. In fact, the diagnosis of pancreatic duct adenocarcinoma is delayed by the absence of symptoms and specific diagnostic biomarkers. Developed by Cedars-Sinai researchers, an artificial intelligence tool was trained on CT images taken months … Read more

Pioneering cooperation in research: Medi-Globe Group and IHU Strasbourg develop the world’s first AI software for the detection of pancreatic diseases

Pioneering cooperation in research Medi Globe Group and IHU Strasbourg develop

ACHENMÜHLE, Germany, April 29, 2022–(BUSINESS WIRE)–The Medi-Globe group has just launched a pioneering research cooperation with the Institut Hospitalo-Universitaire (IHU) in Strasbourg. The goal of the collaboration is to develop the world’s first AI-powered software for the detection of pancreatic diseases during endoscopic ultrasound examinations. As an industrial partner of the IHU, the Medi-Globe group … Read more